Christopher M Ryan1, Barbara E K Klein2, Kristine E Lee2, Karen J Cruickshanks3, Ronald Klein2. 1. Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States. Electronic address: christopher.ryan@ucsf.edu. 2. Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, United States. 3. Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, United States; Department of Population Health Sciences, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, United States.
Abstract
AIMS: Mild cognitive dysfunction has been identified in children and adults with type 1 diabetes, but most studies have failed to find a relationship between severe hypoglycemia and cognition, despite reports of such associations in older adults with type 2 diabetes. Focusing on older adults with type 1 diabetes, we examined the associations between cognitive performance and recent episodes of severe hypoglycemia, retinal vessel diameters and the presence of micro- and macrovascular complications. METHODS: Cognitive functioning was assessed in 244 participants enrolled in the Wisconsin Epidemiologic Study of Diabetic Retinopathy. The mean (SD; range) age at assessment in 2012-14 was 55.2 (8.3; 37-82) years and the mean (SD) duration of diabetes was 41.1 (5.6) years. Three cognitive domains were assessed in this cross-sectional study: mental efficiency and executive function, nonverbal memory, and verbal memory. RESULTS: Multivariate modeling demonstrated that although age and/or education are most strongly associated with performance on measures of mental efficiency, three diabetes-related variables were also associated with poorer test scores: an episode of severe hypoglycemia in the past year (β=-0.360 [95% CI, -0.672, -0.047]), retinal arteriolar and venular diameters (β=0.140 [95% CI, 0.062, 0.219]; β=-0.127 [95% CI -0.207, -0.047]), and carotid artery plaque (β=-0.372 [95% CI -0.741, -0.003]). In addition, recent severe hypoglycemia was associated with poorer nonverbal memory (β=-0.522 [95% CI, -0.849, -0.194]). CONCLUSIONS: For middle-aged and older adults with long-duration type 1 diabetes, poorer cognition was associated with a recent episode of severe hypoglycemia as well as with the presence of micro- and/or macrovascular conditions. Given the increasing numbers of aging adults with type 1 diabetes, future longitudinal studies are needed to identify causality and to determine whether diabetes management techniques that reduce the onset or severity of vascular complications and hypoglycemia can also reduce the risk of cognitive dysfunction in this population.
AIMS: Mild cognitive dysfunction has been identified in children and adults with type 1 diabetes, but most studies have failed to find a relationship between severe hypoglycemia and cognition, despite reports of such associations in older adults with type 2 diabetes. Focusing on older adults with type 1 diabetes, we examined the associations between cognitive performance and recent episodes of severe hypoglycemia, retinal vessel diameters and the presence of micro- and macrovascular complications. METHODS: Cognitive functioning was assessed in 244 participants enrolled in the Wisconsin Epidemiologic Study of Diabetic Retinopathy. The mean (SD; range) age at assessment in 2012-14 was 55.2 (8.3; 37-82) years and the mean (SD) duration of diabetes was 41.1 (5.6) years. Three cognitive domains were assessed in this cross-sectional study: mental efficiency and executive function, nonverbal memory, and verbal memory. RESULTS: Multivariate modeling demonstrated that although age and/or education are most strongly associated with performance on measures of mental efficiency, three diabetes-related variables were also associated with poorer test scores: an episode of severe hypoglycemia in the past year (β=-0.360 [95% CI, -0.672, -0.047]), retinal arteriolar and venular diameters (β=0.140 [95% CI, 0.062, 0.219]; β=-0.127 [95% CI -0.207, -0.047]), and carotid artery plaque (β=-0.372 [95% CI -0.741, -0.003]). In addition, recent severe hypoglycemia was associated with poorer nonverbal memory (β=-0.522 [95% CI, -0.849, -0.194]). CONCLUSIONS: For middle-aged and older adults with long-duration type 1 diabetes, poorer cognition was associated with a recent episode of severe hypoglycemia as well as with the presence of micro- and/or macrovascular conditions. Given the increasing numbers of aging adults with type 1 diabetes, future longitudinal studies are needed to identify causality and to determine whether diabetes management techniques that reduce the onset or severity of vascular complications and hypoglycemia can also reduce the risk of cognitive dysfunction in this population.
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: Hypertension Date: 2003-12-01 Impact factor: 10.190
Authors: Kristine Yaffe; Cherie M Falvey; Nathan Hamilton; Tamara B Harris; Eleanor M Simonsick; Elsa S Strotmeyer; Ronald I Shorr; Andrea Metti; Ann V Schwartz Journal: JAMA Intern Med Date: 2013-07-22 Impact factor: 21.873
Authors: Zubin Punthakee; Michael E Miller; Lenore J Launer; Jeff D Williamson; Ronald M Lazar; Tali Cukierman-Yaffee; Elizabeth R Seaquist; Faramarz Ismail-Beigi; Mark D Sullivan; Laura C Lovato; Richard M Bergenstal; Hertzel C Gerstein Journal: Diabetes Care Date: 2012-02-28 Impact factor: 19.112
Authors: Insa Feinkohl; Phyu Phyu Aung; Marketa Keller; Christine M Robertson; Joanne R Morling; Stela McLachlan; Ian J Deary; Brian M Frier; Mark W J Strachan; Jackie F Price Journal: Diabetes Care Date: 2013-10-08 Impact factor: 19.112
Authors: Alan M Jacobson; Christopher M Ryan; Barbara H Braffett; Rose A Gubitosi-Klug; Gayle M Lorenzi; José A Luchsinger; Victoria R Trapani; Ionut Bebu; Naomi Chaytor; Susan M Hitt; Kaleigh Farrell; John M Lachin Journal: Lancet Diabetes Endocrinol Date: 2021-05-27 Impact factor: 44.867
Authors: Leen J Luyten; Yinthe Dockx; Narjes Madhloum; Hanne Sleurs; Nele Gerrits; Bram G Janssen; Kristof Y Neven; Michelle Plusquin; Eline B Provost; Patrick De Boever; Tim S Nawrot Journal: JAMA Netw Open Date: 2020-07-01
Authors: A Ra Kho; Bo Young Choi; Song Hee Lee; Dae Ki Hong; Beom Seok Kang; Si Hyun Lee; Sang Won Suh Journal: Cells Date: 2022-02-14 Impact factor: 6.600